Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

Clinical trial NCT02048241 · COMPLETED

Trial details

NCT number: NCT02048241
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Intermittent Explosive Disorder Childhood Aggression Oppositional Defiant Disorder Attention Deficit Disorder

Start date: 2011-07-01
Primary completion: 2014-11-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.